{"id":"guanethidine","rwe":[{"pmid":"41640841","year":"2025","title":"Effects of GS-967, GS-6615 and ranolazine on the responses of the rabbit aorta to adrenergic nerve stimulation.","finding":"","journal":"Frontiers in physiology","studyType":"Clinical Study"},{"pmid":"41344494","year":"2026","title":"The impact of guanethidine-induced sympathectomy on satellite glial cell activation in a rat model of neuropathic pain.","finding":"","journal":"Neuroscience letters","studyType":"Clinical Study"},{"pmid":"41313464","year":"2025","title":"Role of capillary rarefaction in age-related changes of external urethral sphincter muscle of female mice.","finding":"","journal":"Cell and tissue research","studyType":"Clinical Study"},{"pmid":"41151410","year":"2025","title":"Metabolic reprogramming of hippocampal endothelial cells contributes to blood-brain barrier dysfunction in perioperative neurocognitive disorder.","finding":"","journal":"Biochemical and biophysical research communications","studyType":"Clinical Study"},{"pmid":"40490991","year":"2025","title":"The thoracic perivascular adipose tissue spontaneously induces vasoconstriction through activation of α(1)-adrenoceptors.","finding":"","journal":"British journal of pharmacology","studyType":"Clinical Study"}],"tags":[{"label":"guanethidine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Alpha-1A adrenergic receptor","category":"target"},{"label":"ADRA1A","category":"gene"},{"label":"ADRA1B","category":"gene"},{"label":"ADRA1D","category":"gene"},{"label":"C02CC02","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Mature","category":"status"},{"label":"Hypertensive disorder","category":"indication"},{"label":"Approved 1960s","category":"decade"},{"label":"Adrenergic Agents","category":"pharmacology"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sympatholytics","category":"pharmacology"}],"phase":"marketed","safety":{"contraindications":["Acute pancreatitis","Anuria","Azotemia","Dehydration","Diabetes mellitus","Gout","Hepatic coma","Hypercalcemia","Hypercholesterolemia","Hyperparathyroidism","Hyperuricemia","Hypochloremic alkalosis","Hypokalemia","Hypomagnesemia","Hyponatremia","Hypovolemia","Neonatal hyperbilirubinemia","Secondary angle-closure glaucoma","Sympathectomy","Systemic lupus erythematosus"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GUANETHIDINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:28:45.068875+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:28:51.284901+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GUANETHIDINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:28:51.505045+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Norepinephrine transporter substrate","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:28:52.557563+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1345/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:28:52.204981+00:00"}},"allNames":"ismelin","offLabel":[],"synonyms":["guanethidine","abapresin","ismelin","octatensine","oktatensin","guanethidine monosulfate","guanethidine sulfate"],"timeline":[{"date":"1960-07-05","type":"positive","source":"DrugCentral","milestone":"FDA approval"},{"date":"1985-03-26","type":"neutral","source":"FDA Orange Book","milestone":"Generic entry — 1 manufacturer approved"}],"approvals":[{"date":"1960-07-05","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Ismelin","ecosystem":[{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null}],"mechanism":{"target":"Alpha-1A adrenergic receptor","novelty":"Follow-on","targets":[{"gene":"ADRA1A","source":"DrugCentral","target":"Alpha-1A adrenergic receptor","protein":"Alpha-1A adrenergic receptor"},{"gene":"ADRA1B","source":"DrugCentral","target":"Alpha-1B adrenergic receptor","protein":"Alpha-1B adrenergic receptor"},{"gene":"ADRA1D","source":"DrugCentral","target":"Alpha-1D adrenergic receptor","protein":"Alpha-1D adrenergic receptor"},{"gene":"ADRA2A","source":"DrugCentral","target":"Alpha-2A adrenergic receptor","protein":"Alpha-2A adrenergic receptor"},{"gene":"ADRA2B","source":"DrugCentral","target":"Alpha-2B adrenergic receptor","protein":"Alpha-2B adrenergic receptor"},{"gene":"ADRA2C","source":"DrugCentral","target":"Alpha-2C adrenergic receptor","protein":"Alpha-2C adrenergic receptor"},{"gene":"SLC6A2","source":"DrugCentral","target":"Sodium-dependent noradrenaline transporter","protein":"Sodium-dependent noradrenaline transporter"}],"modality":"Small Molecule","drugClass":"guanethidine","explanation":"","oneSentence":"","technicalDetail":"Ismelin acts as a presynaptic adrenergic neuron blocker, inhibiting the release of norepinephrine from sympathetic nerve terminals, which leads to a decrease in sympathetic tone and a subsequent decrease in blood pressure."},"commercial":{"launchDate":"1960","_launchSource":"DrugCentral (FDA 1960-07-05, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1342","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GUANETHIDINE","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T11:50:09.748432","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:28:53.849486+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"betanidine","drugSlug":"betanidine","fdaApproval":"","relationship":"same-class"}],"genericName":"guanethidine","indications":{"approved":[{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"mature","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"betanidine","brandName":"betanidine","genericName":"betanidine","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000147861","MMSL":"4808","NDDF":"000639","UNII":"ZTI6C33Q2Q","VUID":"4019770","CHEBI":"CHEBI:5557","VANDF":"4018787","INN_ID":"1024","RXNORM":"203181","UMLSCUI":"C0018318","chemblId":"CHEMBL1345","ChEMBL_ID":"CHEMBL765","KEGG_DRUG":"D02237","DRUGBANK_ID":"DB01170","PUBCHEM_CID":"3518","SNOMEDCT_US":"23814005","IUPHAR_LIGAND_ID":"7194","SECONDARY_CAS_RN":"645-43-2","MESH_DESCRIPTOR_UI":"D006145"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"20%"},"publicationCount":3521,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"C02CC02","allCodes":["C02CC02","C02LF01","S01EX01"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025","pmid":"41640841","title":"Effects of GS-967, GS-6615 and ranolazine on the responses of the rabbit aorta to adrenergic nerve stimulation.","journal":"Frontiers in physiology"},{"date":"2026 Feb 15","pmid":"41344494","title":"The impact of guanethidine-induced sympathectomy on satellite glial cell activation in a rat model of neuropathic pain.","journal":"Neuroscience letters"},{"date":"2025 Dec","pmid":"41313464","title":"Role of capillary rarefaction in age-related changes of external urethral sphincter muscle of female mice.","journal":"Cell and tissue research"},{"date":"2025 Nov 14","pmid":"41151410","title":"Metabolic reprogramming of hippocampal endothelial cells contributes to blood-brain barrier dysfunction in perioperative neurocognitive disorder.","journal":"Biochemical and biophysical research communications"},{"date":"2025 Oct","pmid":"40490991","title":"The thoracic perivascular adipose tissue spontaneously induces vasoconstriction through activation of α(1)-adrenoceptors.","journal":"British journal of pharmacology"}],"companionDiagnostics":[],"genericManufacturers":1,"_genericFilersChecked":true,"genericManufacturerList":["Watson Labs"],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1960","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1960-07-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1960-07-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1960-07-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1960-07-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1960-07-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1960-07-05T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:28:53.849486+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}